Bayesian semiparametric model for sequential treatment decisions with informative timing.

Autor: Oganisian A; Department of Biostatistics, Brown University, Providence, RI, United States., Getz KD; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States., Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, United States., Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Roy JA; Department of Biostatistics and Epidemiology, Rutgers University, Piscataway, NJ, United States.

Publikováno v: Biostatistics (Oxford, England) [Biostatistics] 2024 Oct 01; Vol. 25 (4), pp. 947-961.

Association between oral targeted cancer drug net health benefit, uptake, and spending.

Autor: Lau-Min KS; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Wu Y; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA., Rochester S; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bekelman JE; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA., Kanter GP; Department of Health Policy and Management, Sol Price School of Public Policy, University of Southern California, Los Angeles, CA, USA.; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA., Getz KD; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 01; Vol. 116 (9), pp. 1479-1486.

Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.

Autor: Newman H; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Li Y; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Huang YV; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Elgarten CW; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Myers RM; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ruiz J; Division of Hematology-Oncology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Zheng DJ; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Leahy AB; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Aftandilian C; Division of Pediatric Hematology-Oncology, Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA., Arnold SD; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA., Bona K; Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gramatges MM; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Heneghan MB; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA., Maloney KW; Department of Pediatrics-Hematology/Oncology and Bone Marrow Transplant, University of Colorado Cancer Center, Children's Hospital Colorado, Aurora, Colorado, USA., Modi AJ; Division of Hematology Oncology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas, USA., Mody RJ; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA., Morgan E; Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Winick N; Department of Pediatric Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Wilkes JJ; Division of Cancer and Blood Disorders, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA., Seif AE; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Fisher BT; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Infectious Disease, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Aplenc R; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Getz KD; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (7), pp. e6966.

Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data.

Autor: Cao L; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Huang YS; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Getz KD; Department of Biostatistics, Epidemioloy and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Seif AE; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ruiz J; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Division of Hematology-Oncology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Miller TP; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Fisher BT; Department of Biostatistics, Epidemioloy and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Aplenc R; Department of Biostatistics, Epidemioloy and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Li Y; Department of Biostatistics, Epidemioloy and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Mar; Vol. 71 (3), pp. e30858. Date of Electronic Publication: 2024 Jan 08.

Racial and ethnic disparities in acuity of presentation among children with newly diagnosed acute leukemia.

Autor: Winestone LE; Division of Allergy, Immunology, and BMT, University of California San Francisco (UCSF) Benioff Children's Hospital, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Getz KD; Departments of Biostatistics, Epidemiology, & Informatics and Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Li Y; Departments of Biostatistics, Epidemiology, & Informatics and Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Burrows E; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Scheurer ME; Department of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Tam V; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Gramatges MM; Department of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Wilkes JJ; Department of Pediatrics, Division of Hematology/Oncology, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, Washington, USA., Miller TP; Division of Hematology/Oncology, Emory University, Atlanta, Georgia, USA.; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Seif AE; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Center for Childhood Cancer Research, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Rabin KR; Department of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Fisher BT; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Center for Childhood Cancer Research, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jan; Vol. 71 (1), pp. e30726. Date of Electronic Publication: 2023 Oct 19.